Phillip M - Search Results

1

Plasma IGFBP-3 and its relationship with quantitative growth hormone secretion in short children.

Phillip M, Chalew SA, Kowarski AA, Stene MA. Phillip M, et al. Clin Endocrinol (Oxf). 1993 Oct;39(4):427-32. doi: 10.1111/j.1365-2265.1993.tb02389.x. Clin Endocrinol (Oxf). 1993. PMID: 7507010

2

Effect of testosterone on insulin-like growth factor-I (IGF-I) and IGF-I receptor gene expression in the hypophysectomized rat.

Phillip M, Palese T, Hernandez ER, Roberts CT Jr, LeRoith D, Kowarski AA. Phillip M, et al. Endocrinology. 1992 May;130(5):2865-70. doi: 10.1210/endo.130.5.1315260. Endocrinology. 1992. PMID: 1315260

3

Differential accumulation of insulin-like growth factor-I in kidneys of pre- and postpubertal streptozotocin-diabetic rats.

Phillip M, Werner H, Palese T, Kowarski AA, Stannard B, Bach LA, LeRoith D, Roberts CT Jr. Phillip M, et al. J Mol Endocrinol. 1994 Apr;12(2):215-24. doi: 10.1677/jme.0.0120215. J Mol Endocrinol. 1994. PMID: 7520245

4

Plasma integrated concentration of growth hormone after recombinant human growth hormone injection. Implications for determining an optimal dose.

Chalew SA, Phillip M, Kowarski AA. Chalew SA, et al. Among authors: phillip m. Am J Dis Child. 1993 Mar;147(3):274-8. doi: 10.1001/archpedi.1993.02160270036014. Am J Dis Child. 1993. PMID: 8438807 Clinical Trial.

5

The value of urinary growth hormone determination for assessment of growth hormone deficiency and compliance with growth hormone therapy.

Phillip M, Chalew SA, Stene MA, Kowarski AA. Phillip M, et al. Am J Dis Child. 1993 May;147(5):553-7. doi: 10.1001/archpedi.1993.02160290059026. Am J Dis Child. 1993. PMID: 8488802

6

Urinary cyclic adenosine 3',5'-monophosphate response in McCune-Albright syndrome: clinical evidence for altered renal adenylate cyclase activity.

Zung A, Chalew SA, Schwindinger WF, Levine MA, Phillip M, Jara A, Counts DR, Kowarski AA. Zung A, et al. Among authors: phillip m. J Clin Endocrinol Metab. 1995 Dec;80(12):3576-81. doi: 10.1210/jcem.80.12.8530601. J Clin Endocrinol Metab. 1995. PMID: 8530601

7

The relationship of growth rate, plasma growth hormone (GH) concentration, and GH-binding protein.

Phillip M, Chalew SA, McCarter RJ Jr, Amit T, Kowarski AA, Hochberg Z. Phillip M, et al. Metabolism. 1996 Apr;45(4):424-9. doi: 10.1016/s0026-0495(96)90214-0. Metabolism. 1996. PMID: 8609826

8

Effect of six months of growth hormone therapy, followed by treatment withdrawal in short children with normal quantitative indexes of growth hormone secretion.

Chalew SA, Phillip M, Kowarski AA. Chalew SA, et al. Among authors: phillip m. J Pediatr. 1996 Sep;129(3):456-8. doi: 10.1016/s0022-3476(96)70083-5. J Pediatr. 1996. PMID: 8804340

9

Short-term growth hormone therapy increases serum lipoprotein (a) levels in normal short children without growth hormone deficiency.

Hershkovitz E, Leiberman E, Limony Y, Shany S, Phillip M. Hershkovitz E, et al. Among authors: phillip m. Horm Res. 1996 Jul;46(1):38-40. doi: 10.1159/000184975. Horm Res. 1996. PMID: 8854138

10

An early rise in urine N-telopeptide predicts the growth response of normal prepubertal short children to growth hormone therapy.

Phillip M, Hershkovitz E, Limoni Y, Leiberman E, Belotserkovsky O, Douvdevani A, Weber D. Phillip M, et al. J Pediatr Endocrinol Metab. 1996 Sep-Oct;9(5):519-21. doi: 10.1515/jpem.1996.9.5.519. J Pediatr Endocrinol Metab. 1996. PMID: 8961127

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

475 results

Search Page

Filters